跳至主要内容
临床试验/EUCTR2012-004504-35-IT
EUCTR2012-004504-35-IT进行中(未招募)不适用

The use of Oxytocin as adjunctive therapy for the treatment of schizophrenia: a randomized, double blind trial - OxIS (Oxytocin Intranasal in Schizophrenia)

IRCCS CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI0 个研究点开始时间: 2013年4月10日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Outpatients with a diagnosis of Schizophrenia, according to DSM-IV criteria, for at least one year, assessed via SCID-I/P.
  • -A minimum PANSS total score of 55 (indicating moderate severity, due to ongoing AP treatment) at T0 and a score of at least 4 on the PANSS suspiciousness subscale.
  • -A minimum CGI-S score of 4
  • -Age between 18 and 35 years
  • -A disorder duration of no longer than 5 years
  • -Women of childbearing age must test negative for pregnancy at the time of enrolment
  • - Have at least one family member, or a trusted person, who has daily contact with the patient, and can help him with the management of treatment.
  • All patients must:
  • -be on a therapeutic dose of a SGA (or a maximum 2 SGAs) with no major dose changes for at least 4 weeks.
  • -have the ability to provide informed consent
  • -be able to use a nasal spray
  • -reside in the service catchment area
  • -show evidence of no alcohol or substance abuse/dependence in the last year
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Diagnosis of mental retardation (IQ<70 as assessed via Wechsler Adult Intelligence Scale WAIS)
  • -Diagnosis of organic mental disorder
  • -History of no response to treatment with clozapine
  • -Be on a antipsychotic depot therapy
  • -History of hypersensitivity to OXT or vehicle
  • -Alcohol or substance abuse/dependence in the last year
  • -Presence of, or history of clinically significant allergic rhinitis as assessed by the treating clinician
  • -Being pregnant or breastfeeding
  • -Having given birth in the past 6 months or breast-feeding in the past 3 months
  • -Low literacy as indicated by an inability to read and understand the consent form.

研究者

发起方
IRCCS CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI

相似试验